Your browser doesn't support javascript.
loading
Immune responses in COVID-19 patients during breakthrough infection with SARS-CoV-2 variants Delta, Omicron-BA.1 and Omicron-BA.5.
Bormann, Maren; Brochhagen, Leonie; Alt, Mira; Otte, Mona; Thümmler, Laura; van de Sand, Lukas; Kraiselburd, Ivana; Thomas, Alexander; Gosch, Jule; Braß, Peer; Ciesek, Sandra; Widera, Marek; Dolff, Sebastian; Dittmer, Ulf; Witzke, Oliver; Meyer, Folker; Lindemann, Monika; Schönfeld, Andreas; Rohn, Hana; Krawczyk, Adalbert.
Afiliação
  • Bormann M; Department of Infectious Diseases, West German Centre of Infectious Diseases, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.
  • Brochhagen L; Department of Infectious Diseases, West German Centre of Infectious Diseases, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.
  • Alt M; Department of Infectious Diseases, West German Centre of Infectious Diseases, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.
  • Otte M; Department of Infectious Diseases, West German Centre of Infectious Diseases, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.
  • Thümmler L; Department of Infectious Diseases, West German Centre of Infectious Diseases, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.
  • van de Sand L; Institute for Transfusion Medicine, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.
  • Kraiselburd I; Department of Infectious Diseases, West German Centre of Infectious Diseases, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.
  • Thomas A; Institute for Artificial Intelligence in Medicine, University Hospital Essen, Essen, Germany.
  • Gosch J; Institute for Artificial Intelligence in Medicine, University Hospital Essen, Essen, Germany.
  • Braß P; Institute for Artificial Intelligence in Medicine, University Hospital Essen, Essen, Germany.
  • Ciesek S; Department of Infectious Diseases, West German Centre of Infectious Diseases, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.
  • Widera M; Institute for Medical Virology, University Hospital Frankfurt, Goethe University Frankfurt, Frankfurt am Main, Germany.
  • Dolff S; Institute of Pharmaceutical Biology, Goethe University Frankfurt, Frankfurt am Main, Germany.
  • Dittmer U; Fraunhofer Institute for Molecular Biology and Applied Ecology (IME), Branch Translational Medicine and Pharmacology, Frankfurt am Main, Germany.
  • Witzke O; Institute for Medical Virology, University Hospital Frankfurt, Goethe University Frankfurt, Frankfurt am Main, Germany.
  • Meyer F; Department of Infectious Diseases, West German Centre of Infectious Diseases, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.
  • Lindemann M; Institute for Virology, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.
  • Schönfeld A; Department of Infectious Diseases, West German Centre of Infectious Diseases, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.
  • Rohn H; Institute for Artificial Intelligence in Medicine, University Hospital Essen, Essen, Germany.
  • Krawczyk A; Institute for Transfusion Medicine, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.
Front Immunol ; 14: 1150667, 2023.
Article em En | MEDLINE | ID: mdl-37520539
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: SARS-CoV-2 / COVID-19 Limite: Humans Idioma: En Revista: Front Immunol Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Alemanha
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: SARS-CoV-2 / COVID-19 Limite: Humans Idioma: En Revista: Front Immunol Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Alemanha